Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Navroze Mehta
AddedMar 31, 2024
UpdatedMay 31, 2026
Navroze Mehta

Navroze Mehta

Founder & CEO, KleenGel

CrunchbaseLinkedIn

Navroze Mehta's Career

KleenGel
KleenGel

Boca Raton, FL, US

Founder & CEO· C-Suite · Management
ClearSpec
ClearSpec

Boca Raton, FL, US

Founder & CEO· C-Suite · Management
Impact Medical Strategies
Impact Medical Strategies

Boca Raton, FL, US

Founder & CEO· C-Suite · Management
VenX
VenX

Nashville, TN, US

CEO· C-Suite · Management
Device Innovation Group
Device Innovation Group

Nashville, TN, US

CEO· C-Suite · Management
Mela Artisans
Mela Artisans

Boca Raton, FL, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Navroze Mehta's Career

KleenGel
KleenGel
Seed$300k302012Boca Raton, FL, US
Founder & CEO· C-Suite · Management

Similar to KleenGel

Gant MedicalGant MedicalAlpharetta, GA, USMedical Productsest. 2018Gant MedicalAlpharetta, GA, US · est. 2018

Gant Medical: Manufacturing disposable hygiene products for healthcare, dental, caregiving, and cosmetics industries since 2018.

Seed · $750k30
ClearSpecClearSpecBoca Raton, FL, USMedical Devicesest. 2011ClearSpecBoca Raton, FL, US · est. 2011

ClearSpec LLC: Innovating women's healthcare with advanced, disposable speculums since 2011.

Seed · $600.1k2
ClearLine MDClearLine MDWoburn, MA, USSafety Devicesest. 2016ClearLine MDWoburn, MA, US · est. 2016

ClearLine MD: Advancing operational safety with innovative air intrusion detection devices.

Series A · $5.5M30
CleanEndoCleanEndoMemphis, TN, USMedical Devicesest. 2015CleanEndoMemphis, TN, US · est. 2015

CleanEndo develops tech for efficient pre-cleaning of flexible endoscopes and minimally invasive devices.

Seed · $65k6
ClearSpec
ClearSpec
Seed$600.1k22011Boca Raton, FL, US
Founder & CEO· C-Suite · Management

Similar to ClearSpec

ClearCamClearCamAustin, TX, USSurgical Toolsest. 2018ClearCamAustin, TX, US · est. 2018

ClearCam equips clinicians with innovative tools and tech for enhanced vision and skill in surgery.

Seed · $7.2M12
Clear Image TechnologyClear Image TechnologyElyria, OH, USMedical Devices, Softwareest. 2002Clear Image TechnologyElyria, OH, US · est. 2002

Clear Image Technology, LLC develops diagnostic scope systems and image enhancement software for global healthcare providers.

Seed · $500k30
ClearFlowClearFlowAnaheim, CA, USMedical Devicesest. 1992ClearFlowAnaheim, CA, US · est. 1992

ClearFlow Inc. develops innovative devices for resolving obstructed catheters across various medical segments.

Series A · $39.7M31
KleenGelKleenGelBoca Raton, FL, USMedical Devicesest. 2012KleenGelBoca Raton, FL, US · est. 2012

KleenGel: Providing touch-free, cross-contamination-free medical devices for safe exams since 2012.

Seed · $300k30
Impact Medical Strategies
Impact Medical Strategies
Seed$250k32014Boca Raton, FL, US
Founder & CEO· C-Suite · Management

Similar to Impact Medical Strategies

Turnpoint Medical DevicesTurnpoint Medical DevicesBasking Ridge, NJ, USMedical Devicesest. 2013Turnpoint Medical DevicesBasking Ridge, NJ, US · est. 2013

TurnPoint Medical Devices Inc.: Innovating and commercializing advanced medical technology for improved patient care.

Angel · $9.6M6
PointCare TechnologiesPointCare TechnologiesMarlborough, MA, USMedical Devicesest. 2003PointCare TechnologiesMarlborough, MA, US · est. 2003

PointCare Technologies Inc. develops and markets point-of-care diagnostic products for life-threatening diseases in resource-challenged nations.

Seed · $5.4M30
Ativa MedicalAtiva MedicalSaint Paul, MN, USMedical Devicesest. 2008Ativa MedicalSaint Paul, MN, US · est. 2008

Ativa Medical: Rapid diagnostic test results through innovative medical device manufacturing.

Series A · $36.2M46
Medentum InnovationsMedentum InnovationsClintwood, VA, USMedical Devicesest. 2020Medentum InnovationsClintwood, VA, US · est. 2020

Virginia-based Medentum Innovations advances health equity with affordable, high-performance medical devices.

Angel · $75k5
VenX
VenX
Angel$2.5M72009Nashville, TN, US
CEO· C-Suite · Management

Leadership at VenX

Edward BoyleEdward BoyleFounder
Device Innovation Group
Device Innovation Group
Series A$4M62011Nashville, TN, US
CEO· C-Suite · Management

Leadership at Device Innovation Group

Joe Cook JrJoe Cook JrFounder
Mela Artisans
Mela Artisans
Series A$4M272010Boca Raton, FL, US
CEO· C-Suite · Management

Recent news

Restate raises $7M for its lightweight workflows-as-code platformTechCrunch · 2024

Leadership at Mela Artisans

Sonali Mehta-RaoSonali Mehta-RaoFounder

Navroze Mehta's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to Navroze Mehta

Shubham AgrawalShubham AgrawalCo-Founder · MelaDhilbar RoshanDhilbar RoshanCo-Founder · MelaFrancesco PutignanoFrancesco PutignanoCo-Founder · Mela WorksRiccardo ChiarelliRiccardo ChiarelliCo-Founder · Mela WorksPaul HarrisonPaul HarrisonCo-Founder & CEO · Meld